REG - Feedback PLC - 12 month contract for Sussex CDC pilot extension

FeedbackAnnouncement

06/09/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220906:nRSF3346Ya&default-theme=true

RNS Number : 3346Y  Feedback PLC  06 September 2022

 

Prior to publication, the information contained within this announcement was
deemed by the Company to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of
this announcement, this information is now considered to be in the public
domain.

 

 

Feedback plc

 

 

Feedback awarded twelve month contract for pilot extension in Sussex Community
Diagnostic Centre

 

·      £450,000 contract to cover a 12 month extension of initial pilot
phase of Sussex Health and Care Partnership Integrated Care System ("Sussex
ICS") development programme with Queen Victoria Hospital ("QVH").

·      Follows on from the previously announced memorandum of
understanding ("MOU") to embark on a pilot scheme, providing services with the
exemplar Sussex ICS Community Diagnostic Centre ("CDC") site at QVH.

·      The contract enables extension of the current pilot programme
whilst QVH embarks on a formal procurement process for a solution in the long
term. This procurement is anticipated to be completed in March 2023. The
Company will submit a bid in this subsequent procurement.

 

London, 6th September 2022: Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist clinical infrastructure company, announces that it
has been awarded a twelve-month contract to provide its CDC solution in order
to facilitate an extension of the current CDC pilot in Sussex to further GP
practices and to enable the adoption of further clinical pathways. The
discounted contract is valued at £450,000 and covers the period from 31(st)
March 2022 when the pilot MOU formally ended. The contract will run until
31(st) March 2023 by which point QVH expect to have concluded a formal
procurement for the next phase of the CDC programme rollout, as is required by
NHS procurement policies. Feedback intends to submit a bid in this subsequent
procurement phase.

 

The contract comes as the first live patients go through the CDC pilot as a
result of the MOU signed with the Sussex ICS in October 2021, which was to
embark on a pilot scheme to establish symptom-based pathway models for CDC
services using Feedback's digital infrastructure solutions Bleepa and
CareLocker. QVH in Sussex is one of the UK's exemplar CDC sites and the first
to deliver end-to-end symptom-based pathways through the CDC programme. As
previously announced, the deployment of Feedback's product suite in the Sussex
ICS is intended to be used as a blueprint model for future CDC digital
infrastructure models across the UK.

 

Bleepa's patient-centric design enables clinicians to collaborate on a
patient-by-patient basis across geography, with the clinical discussion
forming an auditable record for the patient episode that is subsequently
shared with all stakeholders. CareLocker's ability to integrate with multiple
clinical systems and centralise data around an individual patient means that
all the diagnostic results can be seen in one place across all provider
groups, ensuring that relevant data can be collected from multiple clinical
settings, travels with the patient and is always available to clinicians.

 

 

Dr Tom Oakley, CEO of Feedback, said: "QVH and the broader Sussex team have
been great partners in delivering this end-to-end clinical solution. This
contract recognises the initial stage of our work together and enables us to
proceed to a more formal working arrangement, pending a successful procurement
exercise.

 

Together we have demonstrated that CDCs can be used to successfully deliver
cross-provider symptom-based diagnostic pathways that transform the patient
journey within the NHS and we expect to be able to show a meaningful impact on
patient waiting lists as a result. ICSs need to adopt a symptom-based pathway
approach to CDCs if they are going to deliver the expected impact on cancer
and elective care waiting times. This pilot is the first example in the
country of how this can be delivered and our digital infrastructure is an
essential component of delivering it."

 

Further information on Feedback and its products can be found on the Company's
website: https://fbkmed.com/feedback-plc/reports-and-presentations/
(https://fbkmed.com/feedback-plc/reports-and-presentations/)

 

 

 

-Ends-

 

Enquiries:

 

 Feedback plc                                    +44 (0) 20 3997 7634

 Tom Oakley, CEO                                 IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Gordon (UK) Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd                                 Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                 (mailto:feedbackplc@walbrookpr.com)
 Paul McManus/Nick Rome/Joe Walker               07980 541 893 or 07748 325 236 or 07407 020 470

 

 

About Feedback

Feedback plc helps clinical teams to make better decisions faster for
patients. We design products that enhance clinician access to patient data and
to their colleagues. Our unique approach centres around individual patient
episodes, into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available to
clinicians in multiple settings, in a format that enables them to meaningfully
interact with it, providing flexibility to clinicians and free movement of
patients between provider settings - clinicians can practice from anywhere and
patients can attend any care provider for investigation and treatment.

 

Our products Bleepa and CareLocker work together to deliver unparalleled value
to our customers. Bleepa is our application layer and sits on top of
CareLocker as our data layer. Bleepa is a clinician facing platform that
displays clinical results from a patient's CareLocker at a certified and
regulated quality, that is suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure, auditable chat
interface that links back to the patient medical record. CareLocker provides
an alternative to traditional system/cloud storage and stores clinical data at
an individual patient level, wrapping relevant clinical data around the
specific patient, ensuring that data is always linked to the patient and is
available to them and any care setting that they attend - it is a federated
data architecture with the patient as the tenant.

 

The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based revenue model is expected to provide increasing levels
of visibility as the Company grows its customer base.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTLAMFTMTTMBLT